CRYOPORT, INC. Current Liabilities
CRYOPORT, INC. (CYRX) had Current Liabilities of $221.04 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $221.04M.
- 2026-03-31: Liabilities, Current $224.87M.
- 2025-12-31: Liabilities, Current $219.02M.
- 2025-09-30: Liabilities, Current $30.75M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $221.04M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $224.87M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $219.02M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $30.75M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $30.15M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $74.03M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $64.56M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $61.44M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $59.88M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $48.98M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $45.61M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $44.91M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $40.25M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $41.58M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $40.85M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $40.73M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $44.05M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $44.44M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $42.65M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $41.07M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $38.15M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $37.87M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $35.02M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $13.19M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $9.44M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $7.07M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $5.46M 10-K · filed 2021-03-01 | $5.46M 10-K · filed 2020-03-10 |
| 2019-09-30 | $5.71M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $5.73M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $4.53M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.06M 10-K · filed 2020-03-10 | |
| 2018-09-30 | $2.79M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $3.13M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $2.44M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $2.20M 10-K · filed 2019-03-13 | $2.19M 10-K · filed 2018-03-08 |
| 2017-09-30 | $1.77M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $1.97M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $2.63M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $2.23M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $2.29M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $2.61M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $2.17M 10-KT · filed 2017-03-13 | |
| 2015-12-31 | $2.47M 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $2.20M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $1.97M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $3.00M 10-K · filed 2016-06-28 | |
| 2014-12-31 | $2.98M 10-Q · filed 2015-02-05 | |
| 2014-09-30 | $2.58M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $2.38M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $4.01M 10-K · filed 2015-05-19 | |
| 2013-12-31 | $1.77M 10-Q · filed 2014-02-13 | |
| 2013-09-30 | $1.04M 10-Q · filed 2013-11-18 | |
| 2013-06-30 | $3.38M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $2.50M 10-K · filed 2014-06-25 | |
| 2012-12-31 | $952.18K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $713.09K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $596.02K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $1.11M 10-K · filed 2013-06-25 | |
| 2011-12-31 | $2.22M 10-Q · filed 2012-02-21 | |
| 2011-09-30 | $2.53M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $3.18M 10-Q · filed 2011-08-15 | |
| 2011-03-31 | $3.24M 10-K · filed 2012-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |